knowledge -WSS

knowledge

author：leisure time 2025-09-03 07:52:17 - browse：535

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： 10 million people disenrolled from Medicaid over past six months

entertainment

WSS

ReNAgade cuts staff seven months after raising $300 million

HPV cancer vaccine study demonstrates efficacy

UnitedHealth’s Optum accused of antitrust violations in California

Diversify hospital leadership teams to protect BIPOC patient health

30 years of 'Listening to Prozac'

What don’t we know about an Alzheimer’s drug side effect?

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Bright Health sells Medicare Advantage business to Molina

Cigna, Humana reportedly in talks to merge

Virginia high school admissions case could be legal follow

10 million people disenrolled from Medicaid over past six months

United colonoscopy coverage change 'may cost lives,' doctors say

BIO selects John Crowley as new CEO

The cancer drug shortage isn’t new — and neither are the solutions

UCSF medical school apologizes for unethical prisoner experiments

Medicare proposal to cover medical devices draws a mixed reaction

As biotech industry slumps, bioscience job market is upside down

explore

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

U.K. Biobank has 500,000 peoples' genome sequences available

CDC director unscathed in first congressional testimony

Rep. Raul Ruiz on the physician shortage and more

With clinical trial data readouts, here's how to spot spin

The Sacklers, horror, and ‘The Fall of the House of Usher’

knowledge

entertainment

leisure time

hotspot